Logo image
Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections
Journal article   Open access   Peer reviewed

Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections

Georgia R Sampedro, Andrea C DeDent, Russell E N Becker, Bryan J Berube, Michael J Gebhardt, Hongyuan Cao and Juliane Bubeck Wardenburg
The Journal of infectious diseases, Vol.210(7), pp.1012-1018
10/01/2014
DOI: 10.1093/infdis/jiu223
PMCID: PMC4207862
PMID: 24740631
url
https://doi.org/10.1093/infdis/jiu223View
Published (Version of record) Open Access

Abstract

Staphyococcus aureus frequently causes recurrent skin and soft-tissue infection (SSTI). In the pediatric population, elevated serum antibody targeting S. aureus α-toxin is correlated with a reduced incidence of recurrent SSTI. Using a novel model of recurrent SSTI, we demonstrated that expression of α-toxin during primary infection increases the severity of recurrent disease. Antagonism of α-toxin by either a dominant-negative toxin mutant or a small molecule inhibitor of the toxin receptor ADAM10 during primary infection reduces reinfection abscess severity. Early neutralization of α-toxin activity during S. aureus SSTI therefore offers a new therapeutic strategy to mitigate primary and recurrent disease.
Animals Bacterial Toxins - antagonists & inhibitors Bacterial Toxins - metabolism Bacterial Toxins - toxicity Hemolysin Proteins - antagonists & inhibitors Hemolysin Proteins - metabolism Hemolysin Proteins - toxicity Male Mice, Inbred C57BL Recurrence Soft Tissue Infections - drug therapy Soft Tissue Infections - pathology Staphylococcal Skin Infections - drug therapy Staphylococcal Skin Infections - pathology Staphylococcus aureus - metabolism Staphylococcus aureus - physiology

Details

Logo image